Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α. (17th August 2022)
- Record Type:
- Journal Article
- Title:
- Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α. (17th August 2022)
- Main Title:
- Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α
- Authors:
- Chander, Yogesh
Kumar, Ram
Verma, Assim
Khandelwal, Nitin
Nagori, Himanshu
Singh, Namita
Sharma, Shalini
Pal, Yash
Puvar, Apurvasinh
Pandit, Rameshchandra
Shukla, Nitin
Chavada, Priyank
Tripathi, Bhupendra N
Barua, Sanjay
Kumar, Naveen - Editors:
- Xia, Xuhua
- Abstract:
- Abstract: Host-dependency factors have increasingly been targeted to minimize antiviral drug resistance. In this study, we have demonstrated that inhibition of p38 mitogen-activated protein kinase (a cellular protein) suppresses buffalopox virus (BPXV) protein synthesis by targeting p38-MNK1-eIF4E signaling pathway. In order to provide insights into the evolution of drug resistance, we selected resistant mutants by long-term sequential passages (P; n = 60) in the presence of p38 inhibitor (SB239063). The P60-SB239063 virus exhibited significant resistance to SB239063 as compared to the P60-Control virus. To provide mechanistic insights on the acquisition of resistance by BPXV-P60-SB239063, we generated p38-α and p38-ϒ (isoforms of p38) knockout Vero cells by CRISPR/Cas9-mediated genome editing. It was demonstrated that unlike the wild type (WT) virus which is dependent on p38-α isoform, the resistant virus (BPXV-P60-SB239063) switches over to use p38-ϒ so as to efficiently replicate in the target cells. This is a rare evidence wherein a virus was shown to bypass the dependency on a critical cellular factor under selective pressure of a drug.
- Is Part Of:
- Molecular biology and evolution. Volume 39:Number 9(2022)
- Journal:
- Molecular biology and evolution
- Issue:
- Volume 39:Number 9(2022)
- Issue Display:
- Volume 39, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 39
- Issue:
- 9
- Issue Sort Value:
- 2022-0039-0009-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08-17
- Subjects:
- p38 -- SB239063 -- virus -- switch to use alternate cellular factor -- drug resistance -- host-directed antiviral agents
Molecular biology -- Periodicals
Molecular evolution -- Periodicals
Evolution, Molecular -- Periodicals
Molecular Biology -- Periodicals
572.8 - Journal URLs:
- http://mbe.oxfordjournals.org/ ↗
http://www.molbiolevol.org/ ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0737-7038;screen=info;ECOIP ↗ - DOI:
- 10.1093/molbev/msac177 ↗
- Languages:
- English
- ISSNs:
- 0737-4038
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.782000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23173.xml